INVESTABOT
Equity Research
XNAS · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Julie Coletti, Align Technology's Executive Vice President and Chief Legal and Regulatory Officer, resigned effective August 1, 2026 to become Chief Legal Officer at Illumina. No successor has been named, leaving …
TL;DR: C. Raymond Larkin, Jr. is retiring as Chairman of Align Technology's Board effective July 1, 2026, after more than two decades of service, with Kevin Conroy appointed as his successor on the same date.
TL;DR: Align Technology reported Q1 2026 revenue of $1.04B, up 6.2% from $979M a year ago, with Clear Aligner shipments hitting a record 685,700 cases. Management beat its own outlook across the board but turned cautious…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/20/2026 | Vitalone Britt J. | — | OPTION_EXERCISE | 1,443 | — | — |
| 5/20/2026 | Vitalone Britt J. | — | OPTION_EXERCISE | -1,443 | — | — |
| 5/20/2026 | Vitalone Britt J. | — | GRANT | 1,836 | — | — |
| 5/20/2026 | SIEGEL SUSAN E | — | OPTION_EXERCISE | 1,745 | — | — |
| 5/20/2026 | SIEGEL SUSAN E | — | OPTION_EXERCISE | -1,745 | — | — |
| 5/20/2026 | SIEGEL SUSAN E | — | GRANT | 1,836 | — | — |
| 5/20/2026 | Saia Andrea Lynn | — | OPTION_EXERCISE | 1,745 | — | — |
| 5/20/2026 | Saia Andrea Lynn | — | OPTION_EXERCISE | -1,745 | — | — |
| 5/20/2026 | Saia Andrea Lynn | — | GRANT | 1,836 | — | — |
| 5/20/2026 | Poul Mojdeh | — | OPTION_EXERCISE | 1,745 | — | — |
| 5/20/2026 | Poul Mojdeh | — | OPTION_EXERCISE | -1,745 | — | — |
| 5/20/2026 | Poul Mojdeh | — | GRANT | 1,836 | — | — |
| 5/20/2026 | Myong Anne | — | OPTION_EXERCISE | 1,745 | — | — |
| 5/20/2026 | Myong Anne | — | OPTION_EXERCISE | -1,745 | — | — |
| 5/20/2026 | Myong Anne | — | GRANT | 1,836 | — | — |
| 5/20/2026 | LARKIN C RAYMOND JR | — | OPTION_EXERCISE | 2,326 | — | — |
| 5/20/2026 | LARKIN C RAYMOND JR | — | OPTION_EXERCISE | -2,326 | — | — |
| 5/20/2026 | LARKIN C RAYMOND JR | — | GRANT | 2,448 | — | — |
| 5/20/2026 | Dallas Kevin J | — | OPTION_EXERCISE | 1,745 | — | — |
| 5/20/2026 | Dallas Kevin J | — | OPTION_EXERCISE | -1,745 | — | — |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 5/11/2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 7,953,988 | $1,920,331,311 | — | 8/13/2024 |
| Vanguard Group | 8,179,779 | $1,277,272,490 | — | 1/29/2026 |
| BlackRock | 4,419,366 | $745,370,304 | 3.0% | 8/7/2026 |
| BlackRock | 4,289,924 | $735,421,666 | -1.6% | 5/13/2026 |
| Fidelity (FMR) | 4,060,032 | $684,765,036 | 50.4% | 8/13/2026 |
| BlackRock | 4,360,560 | $680,901,562 | — | 2/12/2026 |
| Goldman Sachs | 3,388,760 | $571,548,262 | 87.5% | 8/14/2026 |
| Fidelity (FMR) | 2,700,359 | $462,922,562 | 35.0% | 5/15/2026 |
| State Street | 2,558,512 | $431,518,634 | 1.7% | 8/7/2026 |
| State Street | 2,516,254 | $431,361,423 | -0.5% | 5/15/2026 |
| State Street | 2,528,258 | $394,787,487 | — | 2/13/2026 |
| Fidelity (FMR) | 1,999,531 | $312,226,710 | — | 2/17/2026 |
| Goldman Sachs | 1,807,451 | $309,851,408 | 131.5% | 5/15/2026 |
| AQR Capital | 1,196,428 | $186,822,242 | — | 2/17/2026 |
| Morgan Stanley | 1,013,322 | $173,714,059 | 7.3% | 5/15/2026 |
| Morgan Stanley | 1,013,842 | $170,994,867 | 0.1% | 8/13/2026 |
| Citadel Advisors | 939,525 | $161,062,771 | 9.5% | 5/15/2026 |
| AQR Capital | 899,731 | $151,163,848 | 0.7% | 8/14/2026 |
| AQR Capital | 893,206 | $150,255,155 | -25.3% | 5/15/2026 |
| Morgan Stanley | 944,850 | $147,538,620 | — | 5/27/2026 |